Centrix, Inc

Form 483 issued March 2, 2022 · Shelton, Connecticut

Inspection
Feb 9 – Mar 2, 2022
Investigator
Samir C. Gala
Observations
6
Pages
6
FEI number
1281412

In short: On March 2, 2022, FDA issued a Form 483 with 6 observations to Centrix, Inc in Shelton, Connecticut (FEI 1281412) after an inspection that ran Feb 9 – Mar 2, 2022. The investigator was Samir C. Gala. Most observations concern laboratory controls and materials.

At a glance

Observations span 4 systems, led by laboratory controls.

Laboratory controls1
Materials1
Packaging & labeling1
Production1
Other2

What FDA observed

Preview: the opening words of each observation
  1. 01

    There is no written testing program designed to assess the stability…

  2. 02

    Each container or grouping of containers of components is not examined visually upon receipt and before…

  3. 03

    Strict control is not exercised over labeling issued for use in…

  4. 04

    Written production and process control procedures are not followed in the execution of production…

2 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Centrix, Inc?

FDA listed 6 observations on this Form 483, mostly about laboratory controls, materials and packaging & labeling. The opening words of each observation are shown on this page.

Who inspected Centrix, Inc?

Samir C. Gala is named on this Form 483, for the inspection of Feb 9 – Mar 2, 2022. Each investigator has a profile showing what they cite most.

When was Centrix, Inc inspected by FDA?

The inspection ran Feb 9 – Mar 2, 2022, and the Form 483 is dated March 2, 2022.

How do I get the full Form 483 for Centrix, Inc?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free